Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Kim, Su Hyeong ^a   Sehrawat, Anuradha ^a   Sakao, Kozue ^a   Hahm, Eun Ryeong ^a   Singh, Shivendra V ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JAGGED1; JAGGED2; MEMBRANE PROTEIN; NICASTRIN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; PHENETHYL ISOTHIOCYANATE; PRESENILIN 1; UNCLASSIFIED DRUG; ISOTHIOCYANIC ACID DERIVATIVE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL NUCLEUS; CELL STRAIN LNCAP; CONTROLLED STUDY; DU145 CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MIGRATION INHIBITION; MOUSE; NONHUMAN; PC 3 CELL; PROSTATE CANCER; PROSTATE TUMOR; PROTEIN CLEAVAGE; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR XENOGRAFT; UPREGULATION; CELL MOTION; DRUG EFFECT; GENETICS; MALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

MUS; RODENTIA;

CELL LINE, TUMOR; CELL MOVEMENT; HUMANS; IMMUNOHISTOCHEMISTRY; ISOTHIOCYANATES; MALE; PROSTATIC NEOPLASMS; RECEPTORS, NOTCH; RNA INTERFERENCE;

EID: 80055055833     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026615     Document Type: Article

References (45)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer Statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Surh YJ, (2003) Cancer chemoprevention with dietary phytochemicals. Nat Rev Cancer 3: 768-780.
3. Hecht SS, (2000) Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32: 395-411.
4. Kolonel LN, Hankin JH, Whittemore AS, Wu AH, Gallagher RP, et al. (2000) Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol Biomarkers Prev 9: 795-804.
5. Barve A, Khor TO, Hao X, Keum YS, Yang CS, et al. (2008) Murine prostate cancer inhibition by dietary phytochemicals-curcumin and phenyethylisothiocyanate. Pharm Res 25: 2181-2189.
6. Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, et al. (2011) Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J Natl Cancer Inst 103: 571-584.
7. Wattenberg LW, (1977) Inhibition of carcinogenic effects of polycyclic hydrocarbons by benzyl isothiocyanate and related compounds. J Natl Cancer Inst 58: 395-398.
8. Stoner GD, Morrissey DT, Heur YH, Daniel EM, Galati AJ, et al. (1991) Inhibitory effects of phenethyl isothiocyanate on N-nitrosobenzylmethylamine carcinogenesis in the rat esophagus. Cancer Res 51: 2063-2068.
9. Khor TO, Cheung WK, Prawan A, Reddy BS, Kong AN, (2008) Chemoprevention of familial adenomatous polyposis in ApcMin/+ mice by phenethyl isothiocyanate (PEITC). Mol Carcinog 47: 321-325.
10. Xiao D, Lew KL, Zeng Y, Xiao H, Marynowski SW, et al. (2006) Phenethyl isothiocyanate-induced apoptosis in PC-3 human prostate cancer cells is mediated by reactive oxygen species-dependent disruption of the mitochondrial membrane potential. Carcinogenesis 27: 2223-2234.
11. Xiao D, Zeng Y, Choi S, Lew KL, Nelson JB, et al. (2005) Caspase-dependent apoptosis induction by phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent, is mediated by Bak and Bax. Clin Cancer Res 11: 2670-2679.
12. Chiao JW, Wu H, Ramaswamy G, Conaway CC, Chung FL, et al. (2004) Ingestion of an isothiocyanate metabolite from cruciferous vegetables inhibits growth of human prostate cancer cell xenografts by apoptosis and cell cycle arrest. Carcinogenesis 25: 1403-1408.
13. Xiao D, Singh SV, (2010) Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo. Pharm Res 27: 722-731.
14. Ji Y, Kuo Y, Morris ME, (2005) Pharmacokinetics of dietary phenethyl isothiocyanate in rats. Pharm Res 22: 1658-1666.
15. Konsue N, Kirkpatrick J, Kuhnert N, King LJ, Ioannides C, (2010) Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats. Mol Nutr Food Res 54: 426-432.
16. Bommareddy A, Hahm ER, Xiao D, Powolny AA, Fisher AL, et al. (2009) Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res 69: 3704-3712.
17. Xiao D, Powolny AA, Moura MB, Kelley EE, Bommareddy A, et al. (2010) Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem 285: 26558-26569.
18. Nelson WG, De Marzo AM, Isaacs WB, (2003) Prostate cancer. N Engl J Med 349: 366-381.
19. Xu C, Shen G, Chen C, Gélinas C, Kong AN, (2005) Suppression of NF-κB and NF-κB-regulated gene expression by sulforaphane and PEITC through IκBα, IKK pathway in human prostate cancer PC-3 cells. Oncogene 24: 4486-4495.
20. Xiao D, Singh SV, (2007) Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo. Cancer Res 67: 2239-2246.
21. Gong A, He M, Krishna Vanaja DK, Yin P, Karnes RJ, et al. (2009) Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res 53: 878-886.
22. Wang LG, Liu XM, Chiao JW, (2006) Repression of androgen receptor in prostate cancer cells by phenethyl isothiocyanate. Carcinogenesis 27: 2124-2132.
23. Leong KG, Gao WQ, (2008) The Notch pathway in prostate development and cancer. Differentiation 76: 699-716.
24. Mumm JS, Kopan R, (2000) Notch signaling: from the outside in. Dev Biol 228: 151-165.
25. Powolny AA, Singh SV, (2010) Differential response of normal (PrEC) and cancerous human prostate cells (PC-3) to phenethyl isothiocyanate-mediated changes in expression of antioxidant defense genes. Pharm Res 27: 2766-2775.
26. O'Neill CF, Urs S, Cinelli C, Lincoln A, Nadeau RJ, et al. (2007) Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth. Am J Pathol 171: 1023-1036.
27. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, et al. (2007) Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 204: 2935-2948.
28. Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, et al. (2009) Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 15: 452-459.
29. Zhang Y, Wang Z, Ahmed F, Banerjee S, Li Y, et al. (2006) Down-regulation of Jagged-1 induces cell growth inhibition and S phase arrest in prostate cancer cells. Int J Cancer 119: 2071-2077.
30. Wang Z, Li Y, Banerjee S, Kong D, Ahmad A, et al. (2010) Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-κB signaling pathways. J Cell Biochem 109: 726-736.
31. Shou J, Ross S, Koeppen H, de Sauvage FJ, Gao WQ, (2001) Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res 61: 7291-7297.
32. Santagata S, Demichelis F, Riva A, Varambally S, Hofer MD, et al. (2004) JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64: 6854-6857.
33. Alimirah F, Panchanathan R, Davis FJ, Chen J, Choubey D, (2007) Restoration of p53 expression in human cancer cell lines upregulates the expression of Notch1: implications for cancer cell fate determination after genotoxic stress. Neoplasia 9: 427-434.
34. Wakabayashi N, Shin S, Slocum SL, Agoston ES, Wakabayashi J, et al. (2010) Regulation of Notch1 signaling by Nrf2: implications for tissue regeneration. Sci Signal 3: ra52.
35. Clementz AG, Rogowski A, Pandya K, Miele L, Osipo C, (2011) NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications. Breast Cancer Res 13: R63.
36. Kolev V, Mandinova A, Guinea-Viniegra J, Hu B, Lefort K, et al. (2008) EGFR signaling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nat Cell Biol 10: 902-911.
37. Song J, Park S, Kim M, Shin I, (2008) Down-regulation of Notch-dependent transcription by Akt in vitro. FEBS Lett 582: 1693-1699.
38. Belandia B, Powell SM, García-Pedrero JM, Walker MM, Bevan CL, et al. (2005) Hey1, a mediator of notch signaling, is an androgen receptor corepressor. Mol Cell Biol 25: 1425-1436.
39. Xiao D, Johnson CS, Trump DL, Singh SV, (2004) Proteasome-mediated degradation of cell division cycle 25C and cyclin-dependent kinase 1 in phenethyl isothiocyanate-induced G2-M-phase cell cycle arrest in PC-3 human prostate cancer cells. Mol Cancer Ther 3: 567-575.
40. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
41. Scorey N, Fraser SP, Patel P, Pridgeon C, Dallman MJ, et al. (2006) Notch signalling and voltage-gated Na+ channel activity in human prostate cancer cells: independent modulation of in vitro motility. Prostate Cancer Prostatic Dis 9: 399-406.
42. Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, et al. (2004) Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2. Oncogene 23: 5594-5606.
43. Kim YA, Xiao D, Xiao H, Powolny AA, Lew KL, et al. (2007) Mitochondria-mediated apoptosis by diallyl trisulfide in human prostate cancer cells is associated with generation of reactive oxygen species and regulated by Bax/Bak. Mol Cancer Ther 6: 1599-1609.
44. Xiao D, Srivastava SK, Lew KL, Zeng Y, Hershberger P, et al. (2003) Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G2/M arrest and inducing apoptosis. Carcinogenesis 24: 891-897.
45. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 25: 402-408.